AstraZeneca PLC - American Depositary Shares — Financial Statistics (NASDAQ:AZN) | MetaTrader

Open full chart

News

AstraZeneca Says Rare Disease Drug Shows Improvements in Inherited Bone Disorder Despite Missing Key Trial Goal

Flu season is already here. Here’s what to know about this year’s flu shots.

Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times

Cancer Stocks to Consider as Oncology Innovation Accelerates

Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH

Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results

SOPHiA GENETICS, Myriad Genetics Collaborate To Advance New Prostate Cancer-specific Genomic Instability Score Technology

How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings?

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?

Astrazeneca (AZN) Exceeds Market Returns: Some Facts to Consider

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?

AstraZeneca Announces The Opening Of Its Newest Global Strategic Research And Development Center, In Kendall Square, Cambridge, Massachusetts; Co. invests $1B To Grow Massachusetts Workforce By Over 50%